PEL

Piramal Enterprises Limited has submitted to the Exchange the standalone & consolidated financial results along with the Auditors Report for the period ended March 31, 2016.

Piramal Enterprises Limited has informed the Exchange regarding a press release dated May 13, 2016 titled "Piramal Enterprises enters an agreement to acquire four brands from Pfizer Limited for its Consumer Products Business".

Piramal Enterprises Limited has informed the Exchange that the 'Trading Window ' for dealing in the securities of the Company will remain closed from May 10, 20 16 to May 18, 2016 (both days inclusive) i.e. after 48 hours from the time the results are communicated to the Stock Exchange from the date of the meeting.

Ajay G. Piramal has submitted to the Exchange vide letter dated May 2, 2016 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Piramal Enterprises Limited has informed the Exchange regarding the "Schedule of Analyst/ Institutional Investor Meetings".

Piramal Enterprises Limited has informed the Exchange regarding the Schedule of Analyst/ Institutional Investor Meetings.

Piramal Enterprises Limited has informed the Exchange that the Company has acquired a company for a consideration of Rs. 1.50 Lakhs. The consideration amount is nominal since the company so acquired has not undertaken any substantial business operations. Consequent to this acquisition, this company is now a wholly owned subsidiary company of the Company. Details of acquisition are attached herewith.

Piramal Enterprises Limited has informed the Exchange regarding Committee meeting to be held for consideration of issue of non-convertible debentures.

Piramal Enterprises Limited has informed the Exchange that the Company has fixed Record Date as March 19, 2016 for the purpose of payment of interim dividend.

Piramal Enterprises Limited has informed the Exchange that the interim dividend on Equity Shares will be paid to the members between March 23, 2016 and March 30, 2016.

Piramal Enterprises Limited has informed the Exchange that the Board of Directors at its meeting held on March 09, 2016 has declared an interim dividend of Rs 17.50 per Equity Share of face value Rs.2/- (I.e.@875%). The interim dividend on Equity Shares will be paid to the members between March 23, 2016 and March 30, 2016.

Piramal Enterprises Limited has informed the Exchange regarding Presentation made to the Analyst/ Institutional Investor.

Piramal Enterprises Limited has informed the Exchange regarding Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Piramal Enterprises Limited has informed the Exchange that at the Meeting of Committee of Directors (Funding) held on March 01, 2016, the Committee approved the allotment of 1,000 Secured Redeemable Non-Convert ible Debentures (NCD 's), having the Face Value of Rs. 10,00,000/- (Rs. Ten Lakh only) each, aggregating to Rs. 100 Crores. (Revised)

Piramal Enterprises Limited has informed the Exchange that the 'Trading Window' for dealing in the securities of the Company will remain clsoed from March 03, 2016, to the closure of business hours of March 11, 2016(both days inclusive).

Piramal Enterprises Limited has informed the Exchange that at the Meeting of Committee of Directors (Funding) held on February 01, 2016, the Committee approved the allotment of 1,000 Secured Redeemable Non-Convert ible Debentures (NCD 's), having the Face Value of Rs. 10,00,000/- (Rs. Ten Lakh only) each, aggregating to Rs. 100 Crores.

Piramal Enterprises Limited has informed the Exchange regarding a press release dated February 29, 2016 titled "Decision Resources Group Expands into Healthcare Payer Market".

Piramal Enterprises Limited has informed the Exchange regarding the outcome of the Committee meeting held on February 29, 2016.

Piramal Enterprises Limited has informed the Exchange regarding Regulation 8 of the SEBI (Prohibition of Insider Trading ) Regulations, 2015 & Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Piramal Enterprises Limited Code for Fair Disclosure of Information & Determination of Materiality

Piramal Enterprises Limited has informed the Exchange regarding the Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Piramal Enterprises Limited has submitted the Exchange a copy of presentation on "Q3 FY2016".

Piramal Enterprises Limited has informed the Exchange regarding Contact details of Key Managerial Personnel as required under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Piramal Enterprises Limited has informed the Exchange regarding a press release dated February 08, 2016, titled "Piramal Enterprises Limited Consolidated Results for the Q3 FY2016 and 9M FY2016".

Piramal Enterprises Limited has submitted to the Exchange the standalone & consolidated financial results along with the Limited Review Report for the period ended December 31, 2015.

Piramal Enterprises Limited has informed the Exchange that the "Trading Window" for dealing in the securities of the Company will remain closed from February 02, 2016 to February 10, 2016 (both days inclusive) i.e. after 48 hours from the time the results are communicated to the Stock Exchange from the date of the meeting.

The Sri Krishna Trust has submitted to the Exchange, vide letter dated January 22, 2016 a copy of disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Piramal Enterprises Limited has informed the Exchange regarding the allotment of Secured Redeemable Non-Convertible Debentures (NCDs).

Piramal Enterprises Limited has informed the Exchange regarding a press release dated January 12, 2016 titled "Piramal Enterprises announces sale of its Canada-based cartilage repair product, BST-CarGel to Smith & Nephew".

The Sri Krishna Trust has submitted to the Exchange, vide letter dated January 11, 2016 a copy of disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Piramal Enterprises Limited has informed the Exchange that at the meeting of Committee of Directors (Funding) held on January 05, 2016, the Committee approved the issue of secured non-convertible debentures amounting upto Rs. 500 crores.

Piramal Enterprises Limited has informed the Exchange that a meeting of the Committee of Directors (Funding) of the Company will be held on January 5, 2016 to consider and approve the issue of secured non-convertible debentures amounting upto Rs. 500 crores.

Piramal Enterprises Limited has informed the Exchange regarding a press release dated December 22, 2015, titled "Piramal Enterprises acquires five brands from Organon India Pvt.Ltd. (OIPL) and MSD BV for its Consumer Products Business"

Piramal Enterprises Limited has informed the Exchange that Mr. Amit Chandra, Independent Director has resigned from the Board of Directors of the Company w.e.f. December 21, 2015 owing to his other professional commitments.

Piramal Enterprises Limited has informed the Exchange that Result of the voting conducted through Postal Ballot/ E-voting - Clause 35A of the Listing Agreement

Piramal Enterprises Limited has informed the Exchange vide letter dated November 17, 2015 regarding Result of the Voting conducted through Postal Ballot/E-voting-Clause 35A of the Listing Agreement along with Scrutinizers Report.

The Exchange had sought clarification from Piramal Enterprises Limited with respect to a news item captioned "Piramal Enterprises acquires baby care brand". The Company has clarified that "The Company has acquired baby-care brand "Little's" which includes the entire product range across six categories for a consideration of approximately Rs. 73 crores. We would like to state that since the total consideration for this particular acquisition does not exceed Rs. 100 crores and neither will this acquisition impact the Company's consolidated revenue to the extent of Rs. 100 crores, the same has no

The Exchange has sought clarification from Piramal Enterprises Limited with respect to recent news item captioned "Piramal Enterprises acquires baby care brand". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company are aware of any informa

Piramal Enterprises Limited has informed the Exchange regarding "Disclosure under Regulation 3(12) of the SEBI (Share based Employee Benefits) Regulations, 2014 - Inventory held by ESOP Trust".

Piramal Enterprises Limited has submitted to the exchange the standalone & consolidated financial results along with the Limited Review Report for the period ended 30-Sep-2015.

Piramal Enterprises Limited regarding a press release dated November 02, 2015 titled "Piramal Enterprises Limited Consolidated Results for the Q2 FY2016 and H1 FY2016".

Piramal Enterprises Limited has informed the Exchange that the 'Trading Window' for dealing in the securities of the Company is closed from October 24, 2015 to November 4, 2015.

Piramal Enterprises Limited has submitted to the Exchange a copy of the Postal Ballot Notice, Pursuant to Section 110 of the Companies Act, 2013.

The Exchange had sought clarification from Piramal Enterprises Limited with respect to a news item captioned "Piramal to Hold 35% in Combo Entity with IL&FS". The Company has clarified that "The Company from time to time explores various investment opportunities as part of its business strategy. This evaluation of opportunities includes various criteria, including technical, financial, taxation, commercial, regulatory and legal. Once these criteria are met, it is followed by internal approvals at various levels, post which, comes a comprehensive financial and legal diligence. Projects that com

The Exchange has sought clarification from Piramal Enterprises Limited with respect to recent news item captioned "Piramal to Hold 35% in Combo Entity with IL&FS". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company are aware of any infor

Piramal Enterprises Limited has informed the Exchange regarding a clarification on a news item captioned "Piramal exists Omkar's Mumbai Project". The Company has clarified that "The investment of INR 200 crores in the Omkar project referred to in the news article, was made by the Indiareit Domestic Scheme IV which is managed and advised by Piramal Fund Management Private Limited (wholly owned subsidiary of the Company) ('PFMPL'). The investment was not made by PFMPL, nor by the Company. PFMPL is the Investment Manager of Indiareit Domestic Scheme IV. Both the investment referred to above and t

Piramal Enterprises Limited has submitted to the Exchange the Revised outcome of Annual General Meeting of the Company held on the August 06, 2015 as per clause 35A of Listing agreement.

Piramal Enterprises Limited has informed the Exchange that the AGM of the Shareholders of the Company was held on August 06, 2015 and that all the resolutions mentioned in the notice dated May 07, 2015 of the AGM, were passed with an overwhelming requisite majority.Furthet, the Company has submitted to the Exchange the requirements of Clause 35A of the Listing Agreement.

The Exchange had sought clarification from Piramal Enterprises Limited with respect to a news item captioned "Piramal Likely to Hive Off Its Critical Care Business". The Company has clarified that "As part of its strategy, the Company continually evaluates strategic initiatives with the objective of adding value to its shareholders. As per established practice, only those initiatives that are definitive and which are disclosable events, are disclosed to the Stock Exchanges. In this regard, the Company would like to clarify that there is no such proposal as referred to in the captioned news art

The Exchange has sought clarification from Piramal Enterprises Limited with respect to recent news item captioned "Piramal Likely to Hive Off Its Critical Care Business". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company are aware of an

Piramal Enterprises Limited has submitted to the Exchange the outcome of Annual General Meeting of the Shareholders of the Company and 35A of Listing agreement.